Comparative Efficacy of Lipid Based Artificial Tears vs Aqueous Based Artificial Tears in Managing EDE

Inclusion Criteria: * Adults (both genders) aged 18-55 years diagnosed with evaporative dry eye (EDE). * Willingness to adhere to the prescribed treatment regimen (lipid-based or aqueous-based artificial tears). * Include patients with a history of dry eye symptoms for at least 1-3 months. * Ocular Surface Disease Index (OSDI) score ≥13, indicating the presence of mild to severe dry eye symptoms. * Patients with tear break-up time (TBUT) \<10 seconds, indicating tear film instability. Exclusion Criteria: * Use of any topical ophthalmic medications (e.g., lubricants, anti-inflammatory drugs, or cyclosporine) for dry eye within the last 1 month. * Active ocular infection or inflammation (e.g., conjunctivitis, uveitis). * History of ocular surgery or trauma within the past 6 months. * Participants currently wearing contact lenses or those who have worn contact lenses in the past three months. * Systemic conditions known to impact ocular surface health, such as uncontrolled diabetes, autoimmune disorders, or Sjögren's syndrome.